[Oliguria and rise in creatine phosphokinase as a side-effect of citalopram].
Vich Pérez
P
P
Ruiz Arribas
C
C
Collados Navas
R
R
Pastor-Sánchez
R
R
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D015283:Citalopram / Q000008:administration & dosage / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009846:Oliguria / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D003402:Creatine Kinase; D017367:Selective Serotonin Reuptake Inhibitors